Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma-Reference-Cited by-同舟云学术

Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma

Published:2003-01-03 Issue:2 Volume:97 Page:457-464
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Arinaga Mitsuyuki,Noguchi Tsuyoshi,Takeno Shinsuke,Chujo Masao,Miura Takashi,Uchida Yuzo

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference45 articles.

1. Prognosis and survival in resected lung carcinoma based on the new international staging system

2. Conventional clinicopathologic prognostic factors in surgically resected nonsmall cell lung carcinoma

3. Blood vessel invasion by tumor cells predicts recurrence in completely resected T1 N0 M0 non-small-cell lung cancer

4. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma: Correlation with TNM stage and disease free and overall survival

5. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.

Cited by 139 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and future directions on small molecule VEGFR inhibitors in oncological conditions;European Journal of Medicinal Chemistry;2024-06

2. Plasma Angiogenic Factors as Predictors of the Efficacy of Second-line Chemotherapy Combined with Angiogenesis Inhibitors in Metastatic Colorectal Cancer: Results From the GI-SCREEN CRC-Ukit Study;Clinical Colorectal Cancer;2024-06

3. Receptor tyrosine kinase gene expression profiling of orbital rhabdomyosarcoma unveils MET as a potential biomarker and therapeutic target;Human Cell;2023-11-02

4. Vascular endothelial growth factor-C and its receptor-3 signaling in tumorigenesis;3 Biotech;2023-09-01

5. Molecular Pathology of Lung Tumors;Pathology of Lung Disease;2021